Abstract:Objective Lectin-like Ox-LDL receptor-1 (LOX-1), a novel vascular receptor for oxidized LDL, is responsible for recognition and internalization of ox-LDL in vascular cells. It also mediates a spectrum of pro-atherogenic cellular responses implicated in the development and progression of atherosclerosis including endothelial dysfunction and apoptosis, vascular inflammation, foam cell formation and collagen deposition. Previous studies revealed that expression of LOX-1 was highly inducible by proinflammatory stimuli, such as tumor necrosis factor-alpha (TNF-α), Ox-LDL and lipopolysaccharide (LPS). We have demonstrated that tanshinone II-A (a diterpene flavonoids isolated from Tanshen) supplementation retarded the atherogenesis progression in ApoE knockout mice via inhibition of LOX-1 expression. Therefore, we hypothesized that tanshinone II-A could also inhibit LOX-1 expression induced by pro-inflammatory stimuli in murine macrophages. Design and Methods RAW264.7 cells and murine peritoneal macrophages were cultured. Quantitative real-time PCR and western blot were used to determine LOX-1 gene and protein expression. Electrophoretic mobility shift assay (EMSA) was performed to demonstrate the nuclear protein binding to NF-κB regulatory element of LOX-1 gene. Results Pretreatment of cultured macrophages with tanshinone II-A inhibited LOX-1 expression induced by Ox-LDL at both protein and mRNA levels in a time- and concentration-dependent manner. The inhibitory effect was also observed in the cells treated with antioxidants or inhibitors of nuclear factor-kappaB (NF-κB). The activation of NF-κB and phosphorylation of inhibitory factor of NF-kappaB-α (IκB-α) induced by Ox-LDL were suppressed by tanshinone II-A in a time- and concentration-dependent fashion. Ox-LDL also enhanced the binding of nuclear protein to NF-κB regulatory element of LOX-1 gene promoter. This effect was abrogated by tanshinone II-A. Furthermore, the DiI-Ox-LDL uptake study demonstrated that tanshinone II-A concentration-dependently diminished Ox-LDL uptake by macrophages. Conclusions Tanshinone II-A suppressed Ox-LDL-induced LOX-1 expression and the subsequent macrophage foam cell formation, by inhibiting NF-κB activation and ROS generation.

The Atheroprotective Role of Lipoxin A4 Prevents Oxldl-Induced Apoptotic Signaling in Macrophages Via JNK Pathway.

Downregulation of activating transcription factor 4 attenuates lysophosphatidycholine-induced inflammation via the NF-κB pathway.

Lipoxin A4 and its analog attenuate high fat diet-induced atherosclerosis via Keap1/Nrf2 pathway

Lipoxin A4 Inhibits Lipopolysaccharide-induced Differentiation of RAW264.7 Murine Macrophages into Dendritic-like Cells and Its Maturation

DC-SIGN and Toll-like receptor 4 mediate oxidized low-density lipoprotein-induced inflammatory responses in macrophages

Lp-PLA2 Silencing Protects Against Ox-Ldl-induced Oxidative Stress and Cell Apoptosis Via Akt/mTOR Signaling Pathway in Human THP1 Macrophages

Molecular Mechanism of Oxldl Inducing Lipid Accumulation and Inflammation in Macrophages to Promot Atherosclerosisvia TLR4 Signaling Pathway

Dan-Lou Prescription Inhibits Foam Cell Formation Induced by ox-LDL via the TLR4/NF-κB and PPARγ Signaling Pathways

Tanshinone II-A Inhibited Oxidized Low-Density-Lipoprotein Induced LOX-1 Expression in Murine Macrophages by Reduction of Intracellular Reactive Oxygen Species (ROS) and NF-KappaB Activation

LXA4 Inhibits Lipopolysaccharide-Induced Inflammatory Cell Accumulation by Resident Macrophages in Mice

Lipoxin A 4 Inhibits NF-κB Activation and Cell Cycle Progression in RAW264.7 Cells

Macrophage KLF15 prevents foam cell formation and atherosclerosis via transcriptional suppression of OLR-1

L-4f Inhibits Oxidized Low-Density Lipoprotein-Induced Inflammatory Adipokine Secretion Via Cyclic Amp/Protein Kinase A-Ccaat/Enhancer Binding Protein Beta Signaling Pathway In 3t3-L1 Adipocytes

Traditional Chinese Medication Tongxinluo Attenuates Lipidosis in Ox-LDL-Stimulated Macrophages by Enhancing Beclin-1-Induced Autophagy

Latexin deficiency limits foam cell formation and ameliorates atherosclerosis by promoting macrophage phenotype differentiation

Lipoxin A4 suppresses osteoclastogenesis in RAW264.7 cells and prevents ovariectomy-induced bone loss

Lipoxin A4 Negatively Regulates Lipopolysaccharide-Induced Differentiation of RAW264.7 Murine Macrophages into Dendritic-Like Cells.

The effects of ox-LDL in human atherosclerosis may be mediated in part via the toll-like receptor 4 pathway

Oxldl/β2gpi/anti-Β2gpi Complex Induced Macrophage Differentiation to Foam Cell Involving TLR4/NF-kappa B Signal Transduction Pathway

Effects of Lipoxin A_4 on Lipopolysaccharide-induce Oxidative Damage in Macrophage

Oxidized Low-Density Lipoprotein Promotes Macrophage Lipid Accumulation via the Toll-Like Receptor 4-Src Pathway